The cost-effectiveness of surgical instrument management policies to reduce the risk of vCJD transmission to humans

Journal of the Operational Research Society

Volumn 60, Issue 4, 2009, Pages 506-518

  Stevenson, M D ^a   Oakley, J E ^b   Chick, S E ^c   Chalkidou, K ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c INSEAD   (France)

^d NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; DISCRETE EVENT SIMULATION; SURGERY; SURGICAL EQUIPMENT;

DISCRETE-EVENT SIMULATION MODEL; DYNAMICS OF INFECTIONS; MANAGEMENT STRATEGIES; OPERATIONAL RESEARCH; RETROSPECTIVE ANALYSIS; STERILIZATION TECHNIQUES; SURGICAL INSTRUMENT; VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD);

COST BENEFIT ANALYSIS;

EID: 62349105952     PISSN: 01605682     EISSN: 14769360     Source Type: Journal    
DOI: 10.1057/palgrave.jors.2602580     Document Type: Article

References (39)

1. Andrews NJ (2007). Incidence of variant Creutifeldt Jakob disease diagnoses and deaths in the UK January 1994-December 2007. Available from http://www.cjd.ed.ac.uk/cjdq56.pdf.1
2. Baxter RL, Baxter HC, Campbell GA, Grant K, Jones A, Richardson P and Whittaker G (2006). Quantitative analysis of residual protein contamination on reprocessed surgical instruments. J Hosp Infect 63(4): 439-444.
3. Bennett P, Hare A and TownshendJ(2005). Assessing the risk of vCJD transmission via surgery: Models for uncertainty and complexity. J Opl Res Soc 56: 202-2l3.
4. Bishop MT, Hart P, Aitchison L, Baybutt HN. Plinston C, Thomson V, Tuzi N, Head M, Ironside J and Will R (2006). Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5(5): 393-398.
5. Brennan A, Chick SE and Davies R (2006). A taxonomy of model structures for economic evaluation of health technologies. Health Econ 15: 1295-1310.
6. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H and Bostock CJ (1997). Transmissions to mice indicate that 'new variant CJD is caused by the BSE agent. Nature 389(6650): 498-501.
7. Bruce ME, McConnell I, Will RG and lronsidc JW (2001). Detection of variant Creutzfeldt Jakob disease infectivity in extraneural tissues. Lancet 358(9277): 208-209.
8. Chick SE (2001). inpuL distribution selection for simulation experiments: Accounting for input uncertainty. Opns Res 49(5): 744-758.
9. Clarke P and Ghani AC (2005). Projections of the future course of the primary vCJD epidemic in the UK: Inclusion of subclinical infection and the possibility of wider genetic susceptibility. J R Soc Interface 2: 19 31.
10. Currie CSM, Williams BG, Cheng RC and Dye C (2003). Tuberculosis epidemics driven by H1V: is prevention better than cure? AIDS 17: 2501- style="background-color: #000000"2508.
11. Davies R, Roderick P and Raftery J (2003). The evaluation of disease prevention and treatment using simulation models. Eur J Opns Res 150: 53-66.
12. Department of Health (2006a). Assessing the risk of vCJD transmission via surgery. An interim review. Econ Stat Opl Res (cited 10/11/06). Available from http:I/www.dh.gov.uk/assetRoot/04/11/35/42/04113542.pdf.
13. Department of Health (2006b). Chief Executive BulleLin Issue 37 (cited 10/11/06). Available from hltp://www.publications.doh.gov.uk/cebulletinl9oct. htm#l.
14. Fenwiek E, Claxton K and Sculpher M (2001). Representing uncertainly: The role of cost-effectiveness acceptability curves. Health Econ 10: 779-787.
15. Garske T, Clarke PS, Ward H, Will RG and Ghani AC (2006). Factors detemining the potential for onward transmission of vCJD via surgical instruments. J R Soc Interface 3(11): 757-766.
16. Geweke J (1989). Bayesian inference in econometric models using Monte Carlo integration. Econometrica 57(6): 1317-1339.
17. Ghani AC, Ferguson NM, Donnelly CA and Anderson RM (2003). Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc Roy Soc Ser B 270: 689-698.
18. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D and Ironside JW (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203: 733-739.
19. Hospital Episode Statistics (2006) (cited 01/09/06). Available from http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID =1937&categorylD= 192.
20. inglehart DL (1975). Simulating stable stochastic systems, V: Comparison of ratio estimators. Naval Res Logist Quart 22: 553-565.
21. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, Ritchie DL, McCardle LM and Hilton DA (2006). Variant Creutzfeldt-Jakob disease: Prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332(755l): 1186-118.
22. Jacquez JA (1996). Compartmental Analysis in Biology and Medicine, 3rd edn. BioMedWare: Ann Arbor, Michigan, USA.
23. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J and Will R (2004). Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417-421.
24. Merrick JRW, van Dorp JR and Dinesh V (2005). Assessing uncertainty in simulation based maritime risk assessments. Risk Anal 25(3): 731-743.
25. National Institute of Clinical Excellence (2004). Guide to the Methods of Technoiogy Appraisal. Draft for consultation November 2007. Cited 20/02/08. National Institute of Clinical Excellence. Available from http://www.nice.org.uk/media/8AE/5C/TAMcrhodsguideUpdateFinalforConsultation28 11 07.pdf.
26. National institute for Health and Clinical Excellence (2006). Patient safety and the risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures (cited 25/11/06). Available from http://www.nice.org. uk/guidance/IPG196/guidance/pdf/English.
27. Office for National Statistics (2006). Interim Life Tables, United Kingdom 2003-2005 http://www.statistics.gov.uk/STATBASE/ Product.asp?vlnk = 14459.
28. O'Hagan A, Buck CE, Danehkhah A, Eiser JE, Garthwaite PH, Jenkinson DJ, Oakley JE and Rakow T (2006). uncertain Judgements: Eliciting Experts' Probahilities, 1st edn. John Wiley and Sons: Chichester.
29. Peden AH, Head MW, Ritchic DL, Bell JE and Ironside JW (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364(9433): 527-529.
30. Pharmaceutical Journal (2004). Preclinical vCJD: Prevalence higher than expected. Pharm J 272(7301): 663.
31. Rauner MS, Brailsford SC and Flessa S (2005). Use of discrete- event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries. J Opl Res Soc 56: 222-233.
32. Stevenson M, Oakley J and Chick SE (2006). Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures-final report (second consultation) (cited 01/09/06). Available from http://www.nice.org.uk/guidance/IPG196/.
33. Taylor DM, Fraser H, McConnell i, Brown DA, Brown KL, Lamza KA and Smith GRA (1994). Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 139(3-4): 313-326.
34. The National Creutzfeldt-Jakob Disease Surveillance Unit, Edinburgh (2007). CJD Statistics (cited 22/08/2007). http://www.cjd.cd.ac.uk/flgures.htm.
35. The Royal College of Surgeons for England (2006). National Prospective Tonsillectomy Audit (cited 10/11/06). Available http://www. entuk.org/members/ audits/tonsil/Tonsillectomyauditreport-pdf.
36. Tomkinson A, Dc Martin 5, Gilchnist CR and Temple M (2005). Instrumentation and patient characteristics that influence postoperative hacmorrhage rates following tonsil and adenoid surgery. Clin Otolaryngol 30: 338-346.
37. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johimnesson M, McCabe C and Lucc BR (2003). Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR task force on good research practices-Modeling studies. Value in Health 6(1): 9-17.
38. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A and Smith PG (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347(9006): 921-925.
39. Zouaoui F and Wilson JR (2003). Accounting for parameter uncertainty in simulation input modeling. IIE Trans 35: 781-792.